Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

A Prospective Research Investigation of Ischemia Using MCG

NCT: NCT06481943 · RECRUITING

NCT IDNCT06481943
StatusRECRUITING
Start Date2024-07-11
SponsorSB Technology, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

PRISM is a prospective, pilot research study that aims to systematically characterize the usefulness of CardiAQ MCG, a bedside magnetocardiography device, in the evaluation of myocardial ischemia and infarction status.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑